Page 29 - Mylan EpiPen Teaching Note

Rep. Elijah Cummings accused Mylan of using a "simple
but corrupt business model" to enrich themselves in the

same manner as Martin Shkreli of Turing Pharmaceuticals

and executives at Valeant Pharmaceuticals.

http://www.businessinsider.com/mylan-ceo-heather-bresch-house-oversight-
committee-hearing-epipen-2016-9

Perhaps the future problem for Mylan lies in the potential
actions the US Government may take to recover what it

has paid out to Mylan on flawed pricing figure.